Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

IFOSFAMIDE

IFOSFAMIDE

Standard Dose
3GM/60ML (50MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview IFOSFAMIDE is listed in Drugs@FDA under application 201689 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE Form and strength INJECTABLE;INJECTION - 3GM/60ML (50MG/ML) Sponsor EXTROVIS Submission history Latest submission status date: 2015-09-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview IFOSFAMIDE is listed in Drugs@FDA under application 201689 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE Form and strength INJECTABLE;INJECTION - 3GM/60ML (50MG/ML) Sponsor EXTROVIS Submission history Latest submission status date: 2015-09-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.